Furthermore, PAD4-mediated peptidyl citrullination is increased in several autoimmune and ischemic diseases, such as rheumatoid arthritis, multiple sclerosis, and myocardial infarction [16, 17]. This evidence concerns the gene PADI4 and rheumatoid arthritis.